Leukapheresis

"Leukapheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor.

Descriptor ID	D007937
MeSH Number(s)	E02.095.160.570 E02.120.285.570 E02.120.527.570 E05.200.500.363.171.570 E05.242.363.171.570
Concept/Terms	Leukapheresis Leukapheresis Leukaphereses Leukocytopheresis Leukocytophereses Leukopheresis Leukophereses Leukocytapheresis Leukocytaphereses Lymphapheresis Lymphapheresis Lymphaphereses Lymphocytopheresis Lymphocytophereses Lymphopheresis Lymphophereses Lymphocytapheresis Lymphocytaphereses

Below are MeSH descriptors whose meaning is more general than "Leukapheresis".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Biological Therapy [E02.095]
Cytapheresis [E02.095.160]
Leukapheresis [E02.095.160.570]
Blood Component Removal [E02.120]
Cytapheresis [E02.120.285]
Leukapheresis [E02.120.285.570]
Leukocyte Reduction Procedures [E02.120.527]
Leukapheresis [E02.120.527.570]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Cytological Techniques [E05.200.500]
Cell Separation [E05.200.500.363]
Cytapheresis [E05.200.500.363.171]
Leukapheresis [E05.200.500.363.171.570]
Cytological Techniques [E05.242]
Cell Separation [E05.242.363]
Cytapheresis [E05.242.363.171]
Leukapheresis [E05.242.363.171.570]

Below are MeSH descriptors whose meaning is related to "Leukapheresis".

Below are MeSH descriptors whose meaning is more specific than "Leukapheresis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Leukapheresis" by people in this website by year, and whether "Leukapheresis" was a major or minor topic of these publications.

Bar chart showing 6 publications over 6 distinct years, with a maximum of 1 publications in 2003 and 2005 and 2011 and 2012 and 2015 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	0	1	1
2005	0	1	1
2011	1	0	1
2012	1	0	1
2015	1	0	1
2016	0	1	1

Below are the most recent publications written about "Leukapheresis" by people in Profiles.

Tanhehco YC, Zantek ND, Alsammak M, Chhibber V, Li Y, Becker J, Wu DW, Foster T, Wehrli G. Vascular access practices for therapeutic apheresis: Results of a survey. J Clin Apher. 2019 Oct; 34(5):571-578.

View in: PubMed
Zhao Y, Ibrahim H, Bailey JA, Linden J, Hickson E, Haynes S, Greene M, Vauthrin M, Weinstein R. Therapeutic plasma exchange performed in tandem with hemodialysis without supplemental calcium in the apheresis circuit. J Clin Apher. 2017 Jun; 32(3):154-157.

View in: PubMed
Galera P, Haynes S, Sulmasy P, Bailey JA, Greene M, Vauthrin M, Brettler D, Liebmann J, Mark Madison J, Weinstein R. Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia. J Clin Apher. 2016 Aug; 31(4):393-7.

View in: PubMed
Klingemann H, Grodman C, Cutler E, Duque M, Kadidlo D, Klein AK, Sprague KA, Miller KB, Comenzo RL, Kewalramani T, Yu N, Van Etten RA, McKenna DH. Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions. Transfusion. 2013 Feb; 53(2):412-8; quiz 411.

View in: PubMed
Strauss RG, Klein HG, Leitman SF, Price TH, Lichtiger B, Martinez F, Reesink HW, Panzer S. Preparation of granulocyte concentrates by apheresis: collection modalities in the USA. Vox Sang. 2011 May; 100(4):426-33.

View in: PubMed
Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Zorsky P, Klug P, Dai L, Hussain M, Thomas AA, Sundaramurthy C. Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study. Immunol Invest. 2010; 39(6):570-86.

View in: PubMed
Gupta S, Zhou P, Hassoun H, Kewalramani T, Reich L, Costello S, Drake L, Klimek V, Dhodapkar M, Teruya-Feldstein J, Hedvat C, Kalakonda N, Fleisher M, Filippa D, Qin J, Nimer SD, Comenzo RL. Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial. Bone Marrow Transplant. 2005 Mar; 35(5):441-7.

View in: PubMed
Cerny J, Slavickova A, Krepelova A, Trneny M, Klener P. Chemotherapy alone may lead to a PCR negative stem cell harvest in transformed lymphoma refractory to rituximab. Haematologica. 2003 Mar; 88(3):ECR06.

View in: PubMed
Szymanski IO, Teno RA, Gandhi JG, Newburger PE. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro. Vox Sang. 1984; 47(5):325-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals